[go: up one dir, main page]

JO3024B1 - صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات - Google Patents

صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات

Info

Publication number
JO3024B1
JO3024B1 JOP/2010/0338A JOP20100338A JO3024B1 JO 3024 B1 JO3024 B1 JO 3024B1 JO P20100338 A JOP20100338 A JO P20100338A JO 3024 B1 JO3024 B1 JO 3024B1
Authority
JO
Jordan
Prior art keywords
formoterol
aerosol formulations
pharmaceutical aerosol
beclometasone dipropionate
dipropionate
Prior art date
Application number
JOP/2010/0338A
Other languages
English (en)
Inventor
Gaetano Brambilla
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42035850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3024(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Application granted granted Critical
Publication of JO3024B1 publication Critical patent/JO3024B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بصيغ صيدلانية تُستخدَم لإعطاء الأدوية عن طريق الاستنشاق. بصفة خاصة، يتعلق الاختراع الحالي بصيغة صيدلانية تشتمل على بكلوميتازون داي بروبيونات وملح الفورموتيرول للاستخدام في وسائل الاستنشاق التي تُعطي جرعة مقاسة مضغوطة (pMDI`s).
JOP/2010/0338A 2009-10-02 2010-09-30 صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات JO3024B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09172083 2009-10-02

Publications (1)

Publication Number Publication Date
JO3024B1 true JO3024B1 (ar) 2016-09-05

Family

ID=42035850

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2010/0338A JO3024B1 (ar) 2009-10-02 2010-09-30 صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات

Country Status (22)

Country Link
US (1) US8420060B2 (ar)
EP (2) EP2482799B1 (ar)
KR (1) KR101778814B1 (ar)
CN (2) CN102548537B (ar)
AR (2) AR078494A1 (ar)
BR (1) BR112012007484A2 (ar)
CA (1) CA2776266C (ar)
CY (2) CY1115266T1 (ar)
DK (2) DK2727582T3 (ar)
ES (2) ES2487626T3 (ar)
HK (2) HK1199214A1 (ar)
HR (2) HRP20140818T1 (ar)
HU (1) HUE029159T2 (ar)
JO (1) JO3024B1 (ar)
ME (1) ME02398B (ar)
PL (2) PL2727582T3 (ar)
PT (1) PT2482799E (ar)
RS (2) RS53514B1 (ar)
RU (1) RU2650175C2 (ar)
SI (2) SI2482799T1 (ar)
TW (1) TWI449523B (ar)
WO (1) WO2011038872A1 (ar)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119777B2 (en) * 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
FI3412277T3 (fi) * 2012-01-25 2023-03-23 Chiesi Farm Spa Kortikosteroidia ja beeta-adrenergista ainetta käsittävä kuivajauheformulaatio annettavaksi inhalaatiolla
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
CN112472689B (zh) 2015-12-04 2023-01-17 墨西哥氟石股份公司 药物组合物
CN112438966B (zh) * 2019-08-30 2022-08-26 四川普锐特药业有限公司 一种医用定量吸入气雾剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
WO1995002651A1 (en) 1993-07-15 1995-01-26 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
IT1317720B1 (it) 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
UA73986C2 (uk) * 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
US6472563B1 (en) * 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1982709A1 (en) * 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
RU2356537C2 (ru) * 2007-07-25 2009-05-27 Закрытое Акционерное Общество (ЗАО) "Пульмомед" Фармацевтический состав дозированных аэрозолей, содержащий противоастматические лекарственные средства в виде суспензий, растворов, эмульсий, растворов и эмульсий

Also Published As

Publication number Publication date
US8420060B2 (en) 2013-04-16
HRP20140818T1 (hr) 2014-10-10
RS54721B1 (en) 2016-08-31
DK2482799T3 (da) 2014-09-01
EP2482799B1 (en) 2014-06-18
CN103919785A (zh) 2014-07-16
PL2727582T3 (pl) 2016-06-30
PT2482799E (pt) 2014-08-06
KR101778814B1 (ko) 2017-09-15
EP2727582B1 (en) 2016-03-16
SI2482799T1 (sl) 2014-10-30
CN103919785B (zh) 2016-08-24
CY1115266T1 (el) 2017-01-04
SI2727582T1 (sl) 2016-05-31
US20110081301A1 (en) 2011-04-07
CA2776266C (en) 2017-11-28
AR123674A2 (es) 2023-01-04
CN102548537B (zh) 2014-06-25
WO2011038872A1 (en) 2011-04-07
ES2568913T3 (es) 2016-05-05
TW201119644A (en) 2011-06-16
DK2727582T3 (en) 2016-05-17
ME02398B (me) 2016-09-20
RU2012112454A (ru) 2013-11-10
HUE029159T2 (hu) 2017-02-28
RU2650175C2 (ru) 2018-04-10
RS53514B1 (en) 2015-02-27
EP2482799A1 (en) 2012-08-08
KR20120100901A (ko) 2012-09-12
HRP20160630T1 (hr) 2016-07-01
CY1117596T1 (el) 2017-04-26
ES2487626T3 (es) 2014-08-22
CN102548537A (zh) 2012-07-04
EP2727582A1 (en) 2014-05-07
AR078494A1 (es) 2011-11-09
TWI449523B (zh) 2014-08-21
PL2482799T3 (pl) 2014-11-28
HK1199214A1 (en) 2015-06-26
CA2776266A1 (en) 2011-04-07
HK1167817A1 (en) 2012-12-14
BR112012007484A2 (pt) 2020-06-09

Similar Documents

Publication Publication Date Title
TW201129359A (en) Pharmaceutical composition for the treatment of COPD
WO2007121913A3 (en) Pharmaceutical solution formulations for pressurised metered dose inhalers
WO2009008001A3 (en) Inhalation device
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
WO2011076841A3 (en) Combination therapy for copd
BR112013002504A2 (pt) formulação farmacêutica para administração em aerosol, inalador pressurizado dosimetrado (pmdi), formulação farmacêutica para nebulização, frasco de dose única ou múltiplas e uso de uma formulação
MX336225B (es) Composiciones que comprenden sulfato de salbutamol.
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
MX368774B (es) Nueva dosificación y formulación.
WO2010011329A3 (en) The delivery of powdered drug via inhalation
MX2014004279A (es) Composiciones que comprenden sulfato de salbutamol.
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
GEP20166479B (en) Aerosol formulation for copd
GB201118188D0 (en) Manufacture of medicinal aerosol canisters
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
WO2012040228A3 (en) Aerosol composition for administering drugs
CY1117596T1 (el) Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
MD20140131A2 (ro) Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
NZ591174A (en) Metered dose inhaler
MX2015015150A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
ZA202207717B (en) Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation
NZ599901A (en) Improved medicinal aerosol formulations
WO2011037549A3 (en) Dry powder formulation of tiotropium carried in blister strip
MX2014001940A (es) Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.